1. Home
  2. REAX vs PRLD Comparison

REAX vs PRLD Comparison

Compare REAX & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Real Brokerage Inc.

REAX

The Real Brokerage Inc.

HOLD

Current Price

$1.99

Market Cap

435.9M

Sector

N/A

ML Signal

HOLD

Logo Prelude Therapeutics Incorporated

PRLD

Prelude Therapeutics Incorporated

HOLD

Current Price

$4.08

Market Cap

391.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REAX
PRLD
Founded
2018
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
435.9M
391.1M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
REAX
PRLD
Price
$1.99
$4.08
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$5.49
$5.67
AVG Volume (30 Days)
4.4M
560.0K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
23.21
EPS
N/A
N/A
Revenue
N/A
$12,140,000.00
Revenue This Year
$23.04
$320.10
Revenue Next Year
$15.98
$100.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
73.43
52 Week Low
$1.55
$0.75
52 Week High
$5.41
$5.69

Technical Indicators

Market Signals
Indicator
REAX
PRLD
Relative Strength Index (RSI) 49.74 40.22
Support Level $1.92 $3.92
Resistance Level $2.30 $4.13
Average True Range (ATR) 0.16 0.38
MACD -0.01 -0.11
Stochastic Oscillator 38.91 7.05

Price Performance

Historical Comparison
REAX
PRLD

About REAX The Real Brokerage Inc.

The Real Brokerage Inc is a technology-powered real estate brokerage firm located in the United States and Canada. It has developed a proprietary transaction management and brokerage operations software called reZEN, which powers nearly all of its brokerage operations, enabling efficiency, automation, and flexibility by incorporating end-to-end transaction management, automated compliance and brokerage oversight, integrated payments and financial services, Leo CoPilot, and open API for customization. In addition, the company also offers mortgage brokering and title services. The company's operating segments are North American Brokerage, which derives key revenue, One Real Title, One Real Mortgage, and Real Wallet. Geographically, it derives key revenue from the United States.

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.

Share on Social Networks: